Cargando…

Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry

Background and objectives: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Among extra-pulmonary manifestations of COPD, atrial fibrillation (AF) is commonly observed in clinical practice. The coexistence of COPD and AF significantly affects the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angeli, Fabio, Reboldi, Gianpaolo, Trapasso, Monica, Aita, Adolfo, Ambrosio, Giuseppe, Verdecchia, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681215/ https://www.ncbi.nlm.nih.gov/pubmed/31324041 http://dx.doi.org/10.3390/medicina55070358

Ejemplares similares

Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
por: Angeli, Fabio, et al.
Publicado: (2019)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
por: Vedovati, Maria Cristina, et al.
Publicado: (2019)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

The revolution of the anti-diabetic drugs in cardiology
por: Verdecchia, Paolo, et al.
Publicado: (2020)

Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
por: Angeli, Fabio, et al.
Publicado: (2022)

COVID-19, vaccines and deficiency of ACE(2) and other angiotensinases. Closing the loop on the "Spike effect"
por: Angeli, Fabio, et al.
Publicado: (2022)

Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study
por: Marazzato, Jacopo, et al.
Publicado: (2021)

Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial
por: Hijazi, Ziad, et al.
Publicado: (2019)

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021)

The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure()
por: Angeli, Fabio, et al.
Publicado: (2023)

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study
por: Verdecchia, Paolo, et al.
Publicado: (2018)

Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
por: Angeli, Fabio, et al.
Publicado: (2021)

Mercury overexposure and atrial fibrillation
por: Guzzi, Gianpaolo, et al.
Publicado: (2016)

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
por: Reboldi, Gianpaolo, et al.
Publicado: (2009)

Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin?()
por: Angeli, Fabio, et al.
Publicado: (2023)

Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study
por: Li, Yan-Ming, et al.
Publicado: (2019)

Obstructive sleep apnea and atrial fibrillation
por: Todd, Keith, et al.
Publicado: (2010)

Obstructive Sleep Apnea and Atrial Fibrillation
por: Moula, Amalia Ioanna, et al.
Publicado: (2022)

Indonesian registry on atrial fibrillation (OneAF)
por: Raharjo, Sunu Budhi, et al.
Publicado: (2021)

Clinical characteristics and thrombotic risk of atrial fibrillation with obstructive sleep apnea: results from a multi-center atrial fibrillation registry study
por: Xu, Wei, et al.
Publicado: (2022)

Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
por: Dong, Zhaojie, et al.
Publicado: (2021)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Management of atrial fibrillation
por: Vergara, Pasquale, et al.
Publicado: (2014)

The “obesity paradox” in patients with atrial fibrillation: Insights from the Gulf SAFE registry
por: Li, Yan-Guang, et al.
Publicado: (2022)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons
por: Verdecchia, Paolo, et al.
Publicado: (2014)

SARS-CoV-2 vaccines: Lights and shadows
por: Angeli, Fabio, et al.
Publicado: (2021)

Rationale and design of the Chinese Atrial Fibrillation Registry Study
por: Du, Xin, et al.
Publicado: (2016)

Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea
por: Saleeb-Mousa, James, et al.
Publicado: (2023)

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry
por: Fudim, Marat, et al.
Publicado: (2018)

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Atrial Fibrillation
por: Gassanov, Natig, et al.
Publicado: (2013)

Atrial fibrillation
por: Munger, Thomas M., et al.
Publicado: (2014)

Atrial Fibrillation
por: Cromie, Nick
Publicado: (2013)

Atrial Fibrillation
por: Erol, Çetin
Publicado: (2022)

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF I) Registry
por: O'Brien, Emily C., et al.
Publicado: (2016)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_llj6obgju6tj74vsaimcd7j395